Table 3

 Echocardiographic, haemodynamic and humoral measures obtained before and 28 days after transjugular intrahepatic portosystemic shunt implantation in 32 patients with cirrhosis

VariableBefore TIPSAfter TIPSp Value
E/A, early maximal filling velocity/late filling velocity; LVEDV, left ventricular end diastolic volume; LVESV, left ventricular end systolic volume; LVEF, left ventricular ejection fraction; RVSP, right ventricular systolic pressure; SVR, systemic vascular resistance; TIPS, transjugular intrahepatic portosystemic shunt.
*The reported data were obtained from 29 patients.
†The analysis was performed on 23 patients. In these patients, at baseline, plasma renin activity was 3.47 (0.78) ng/l⋅s, aldosterone 1548 (355) pmol/l and atrial natriuretic peptide 28 (4.2) pmol/l.
Mean arterial pressure (mm Hg)85 (2)86 (2)0.18
Heart rate (bpm)73 (2)78 (2)0.043
LVEDV (ml)94 (6)111 (5)0.001
LVESV (ml)34 (3)42 (3)0.008
LVEF (%)66 (2)63 (2)0.11
Stroke volume (ml)61 (3)68 (3)0.010
Cardiac output (l/min)4.4 (0.2)5.5 (0.2)<0.001
E/A ratio0.97 (0.05)1.19 (0.08)0.008
Deceleration time (ms)234 (8)216 (8)0.16
RVSP (mm Hg)23 (1)26 (2)0.43
SVR (dyne s/cm5 m2)1639 (77)1310 (54)<0.001
Plasma renin activity (ng/l⋅s)3.2 (0.6)*2.0 (0.47)†0.026
Aldosterone (pmol/l)1642 (319)*971 (164)†0.26
Atrial natriuretic peptide (pmol/l)29 (3.9)*47 (7.46)†0.021